Objective
The GLUCOSTAT project will develop a first to the market, fully integrated, biotechnology device that will enable automatic
control of blood glucose levels for patients in ICUs. This will improve the clinical outcomes for the patient as their blood
glucose concentration will be maintained in the healthy normal concentration range (4-6 mM). Automatic blood glucose
control will also decrease the workload on nurses as they no longer need to take frequent blood samples which will allow this
valuable resource to be re-directed to more valuable roles within the intensive care wards. A move away from discrete
sampling to an automatic control system that maintains low fluctuations will result in a cost reduction of €2,638 per intensive
care unit (ICU) patient and hence be more resource and labour efficient. With an estimated 1.25 million sepsis/diabetes
patients in the EU who will most benefit from continuous glucose monitoring (CGM), the total cost savings of implementing
GLUCOSTAT will be in the order of €3.3 billion.
The GLUCOSTAT project will optimise FLOW’s existing Diramo system and process used for its manufacture, and integrate
the advanced control algorithm from Technical University of Denmark (DTU) to enable FLOW to apply for CE certification.
The performance of the optimised CE marked device will then be evaluated by performing a clinical study where we will
automatically control the blood glucose level of ICU patients to stay within the normal 4-6 mM range. This will demonstrate
the automated blood glucose control system’s effectiveness in terms of delivering good accuracy, usability and robustness,
which will enable FLOW to carry out post project commercialisation and market activities. Once the automatic control system
has been launched, penetrated the market, and proved itself in patients with sepsis and diabetes, a market potential of €4.5
billion can be achieved for FLOW by implementing the device across all ICU patients in the EU and USA.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine critical care medicine
- medical and health sciences clinical medicine endocrinology diabetes
- medical and health sciences medical biotechnology tissue engineering artificial pancreas continuous glucose monitors
- social sciences economics and business business and management commerce
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.4. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Biotechnology
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-2 - SME instrument phase 2
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
6400 SONDERBORG
Denmark
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.